The lymphatic system plays a critical role in pathological conditions such as lymphedema and chronic inflammation to tumor metastasis, venous insufficiency, and impaired wound healing, making accurate evaluation of its structure and function increasingly important.
Chinese Academy of SciencesApr 13 2026 The lymphatic system plays a critical role in pathological conditions such as lymphedema and chronic inflammation to tumor metastasis, venous insufficiency, and impaired wound healing , making accurate evaluation of its structure and function increasingly important.
Yet current imaging tools—including lymphoscintigraphy, magnetic resonance lymphangiography , indocyanine green fluorescence imaging, and conventional methylene blue imaging—often remain limited by invasiveness, poor targeting, high cost, radiation exposure, or insufficient spatial and functional resolution. Although methylene blue is a clinically approved near-infrared dye with a favorable safety profile, it tends to aggregate in water and lacks strong lymphatic specificity because of its very small particle size. Delivering tracers precisely into the dermis also remains a challenge, since standard intradermal injection can be painful and operator-dependent. Based on these challenges, in-depth research is needed to develop safer, more targeted, and more patient-friendly methods for lymphatic imaging. Researchers from Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, together with collaborators from Shanghai Jiao Tong University and Shanghai Children's Medical Center, reported in a 2026 advance article in Burns & Trauma that a methylene blue nanoparticle delivered through dissolvable microneedles enabled noninvasive near-infrared imaging of lymphatic vessels with higher quality, better targeting, and added functional readouts compared with methylene blue or indocyanine green. A "smarter" tracer To build the new platform, the team first encapsulated methylene blue in an MPEG-PCL nanocarrier using a double-emulsion method. This design increased particle size from the sub-10 nm range of free methylene blue to about 99 nm, a size better suited for lymphatic uptake. The resulting nanoparticles also shifted to a slightly negative surface charge, showed improved fluorescence, and resisted the quenching and instability that weaken free methylene blue in aqueous solution. In cell studies, the material showed low cytotoxicity, caused less than 5% hemolysis, and was taken up and transported across lymphatic endothelial cells, supporting its promise as a lymphatic imaging tracer. Painless delivery The group then integrated the tracer into dissolvable microneedles arranged in a 15 × 15 array. These microneedles were mechanically strong enough to pierce skin and released about 80% of their payload in vitro, offering a convenient way to place the tracer into the dermis without conventional needle injection. By targeting only the superficial dermal layer, these ultra-fine needles avoid triggering deep-seated pain receptors, ensuring a virtually sensation-free experience for the patient. Groundbreaking results In animal models, the MPEG-PCL@ME platform outperformed current gold standards like indocyanine green and free ME. Key advantages include:"This study turns a familiar clinical dye into a smarter lymphatic probe," the researchers suggest in essence. By combining nanoscale engineering with dissolvable microneedle delivery, the work addresses several long-standing barriers at once: weak targeting, signal instability, painful administration, and limited ability to assess lymphatic function dynamically. The resulting method is not only easier to use, but also more informative, offering a sharper picture of lymphatic structures and enabling the dynamic assessment of real-time lymph pumping. The implications could extend well beyond imaging convenience. A portable, painless, and nonradioactive system for lymphatic visualization may support earlier diagnosis of lymphatic dysfunction, better monitoring of lymphedema, and more precise assessment of disease processes linked to impaired lymph flow. Because the tracer also demonstrated satisfactory biosafety in vivo, with no obvious pathological changes in major organs and normal routine blood indices, it may be suitable for longer-term lymphography as the technology develops further. With refinement and clinical translation, this approach could help bring lymphatic imaging closer to bedside practice and make functional lymphatic assessment more accessible in everyday medicine.Journal reference:Han, C., et al. . A novel method for targeting lymphatic vessel imaging: methylene blue nanoparticle integrated with dissolvable microneedles. Burns & Trauma. DOI: 10.1093/burnst/tkaf067. https://academic.oup.com/burnstrauma/advance-article/doi/10.1093/burnst/tkaf067/8442833
Chronic Fluorescence Fluorescence Imaging Inflammation Lymphatic System Lymphedema Medicine Metastasis Methylene Blue Particle Size Radiation Exposure Research Skin Trauma Tumor Wound Wound Healing
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Shark's 'quiet and fast' cordless fan slashed by 32% in flash dealIt was originally priced at £129.99 and is being praised for its 'high speeds'
Read more »
Tributes pour in for Poulton boy, 17, who died swimming at Lake District beauty spotAbsi Ahmed got into difficulty in the water at High Dam Tarn
Read more »
Nanodisc technology improves study of viral proteins for vaccinesViruses are masters at invading our cells thanks to specialized proteins that coat their surfaces. When scientists design vaccines, they often create versions of these viral surface proteins to study how our immune systems might respond.
Read more »
Divest away from mining, says the Vatican40-strong religious group launches platform
Read more »
Scientists discover 'natural Ozempic' that has fewer side effectsEarly tests of this molecule have found that it curbs appetite and improves metabolism.
Read more »
Researchers identify molecular link between autoimmune disease and lymphoma riskPatients with autoimmune diseases such as lupus and rheumatoid arthritis have an increased risk of developing lymphoma, a form of blood cancer that affects the lymphatic system.
Read more »